Research programme: rotavirus vaccines - SEEK
Latest Information Update: 16 Jul 2016
At a glance
- Originator PepTcell
- Developer SEEK
- Class Vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Rotavirus-infections in United Kingdom (Parenteral)
- 20 Oct 2009 Early research in Rotavirus infections in United Kingdom (parenteral)